You are here

Cara Livernois
News Writer
As a News Writer at TriMed Media Group, Cara covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing them to market its S4-1 cardia transducer for Lumify.

ZDi Solutions has recently announced the release of its Z-System, an add-on to radiation therapy devices to optimize patient positioning during treatment.

Distinguishing between healthy and cancerous cells just might be the biggest hurdle in cancer care physicians have encountered. A new MRI technique developed by radiologists at UT Southwestern Medical Center in Dallas have fixed that problem using zinc.

Early detection is crucial when treating breast cancerand to that end, researchers have turned to our own bodies to help. A study from Provista Diagnostics looked at two different protein biomarkers to find if they could improve early detection.

Researchers have found patients with high-risk prostate cancer who are treated with a high portion of radical local treatment (radiotherapy or prostatectomy) have half the mortality risk of those who were treated with the lowest proportion.

Watching how something is performed before you try it out can be an excellent teaching tool, especially for those who can’t speak.

Professor Andreas Fouras of Monash University has developed a four-dimensional lung scanning technology platform, helping physicians to detect abnormal lung functions early, reports News Medical.

Scientists from the RIKEN Center for Life Science Technology (CLST) have developed a new PET scan that is able to analyze neuron proliferation in the brain's subventricular and subgranular zones of the hippocampal dentate gyrus, the areas most affected by depression.

Oxygen, the air we breathe and the foundation of life, remains mysterious in terms of seeing it working through our tissues. That is until researchers developed a new tool to show us just how oxygen travels to our tissue.

The new method used to detect androgen receptors and active splice variants could mean better and faster care for patients suffering from prostate cancer.